Clinical trial
Effects of Persistent Innate Immune Activation on Vaccine Efficacy
NCT02429583 is registered in ClinicalTrials.gov with Rockefeller University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Persistent Innate Immune Activation on Vaccine Efficacy
- Lead sponsor
- Rockefeller University
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- May 8, 2015
- Completion date
- November 30, 2018
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis c infection